FI
PRTK

Fosun International’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Fosun International’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-227,383
Closed -$875K – 303
2019
Q2 		$875K Hold
227,383
– – 0.06% 181
2019
Q1 		$1.23M Hold
227,383
– – 0.08% 140
2018
Q4 		$1.2M Buy
+227,383
New +$1.73M 0.07% 121

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Fosun International's PRTK Position: Q3 2019 in Review

Fosun International sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2019, closing a stake of 227,383 shares — an estimated $875K sold.

Fosun International first reported a position in PRTK in Q4 2018 and held it in 3 quarters. The position peaked at $1.23M in Q1 2019. 91 funds tracked by Wall St. Rank hold PRTK as of Q3 2019.

  • Fosun International reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 227,383 Paratek Pharmaceuticals, Inc. shares in Q3 2019, an estimated $875K.
  • Fosun International first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2018 and held it in 3 quarters.
  • Fosun International's Paratek Pharmaceuticals, Inc. position peaked at $1.23M in Q1 2019.
  • 91 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.